Suppr超能文献

DNA引发E和NS1构建体——同源蛋白增强免疫策略以改善小鼠对登革热的免疫反应。

DNA priming E and NS1 constructs--homologous proteins boosting immunization strategy to improve immune response against dengue in mice.

作者信息

Mellado-Sánchez Gabriela, García-Cordero Julio, Luria-Pérez Rosendo, Lázaro-Olan Lucero, Santos-Argumedo Leopoldo, Gutiérrez-Castañeda Benito, Estrada-García Iris, Cedillo-Barrón Leticia

机构信息

Departamento de Biomedicina Molecular Centro de Investigación y Estudios Avanzadas del IPN, Mexico, DF Mexico.

出版信息

Viral Immunol. 2005;18(4):709-21. doi: 10.1089/vim.2005.18.709.

Abstract

DNA priming-protein boosting is a strategy used to establish strong immunity to a specific pathogen by the use of two different antigens through sequential delivery systems. In this work, two recombinant plasmids were used, one encoding for the dengue virus E protein, which is know to induce neutralizing antibodies (pcDNA 3.1/E), and the other encoding for the Dengue virus nonstructural protein 1 (pcDNA 3.1/NS1), as a source of B- and T-cell epitopes possibly involved in protective immunity. We showed that immunization of BALB/c mice with three priming doses of both plasmids pcDNA 3.1/E and/or pcDNA 3.1/NS1 were able to induce antibody responses to E protein with a single plasmid; in contrast to the antibody response to NS1 protein we observed an additive effect in terms of antibody response. Moreover, using a prime-boost protocol in which both plasmid constructs were co-administrated followed by a boost of homologous GST-E and GST-NS1 recombinant proteins, we observed an increased antibody response to NS1 and to E protein compared to animals vaccinated with the proteins or with dengue constructs alone. If neutralizing antibodies play an important role in dengue infection, antibodies generated with this regimen was also significantly better than the administration of the mix of proteins alone. These results suggest that NS1 and E proteins together could be considered in a design of subunit recombinant vaccines.

摘要

DNA 初免-蛋白加强免疫是一种通过使用两种不同抗原经序贯递送系统来建立针对特定病原体的强大免疫力的策略。在本研究中,使用了两种重组质粒,一种编码登革病毒 E 蛋白(已知其可诱导中和抗体,即 pcDNA 3.1/E),另一种编码登革病毒非结构蛋白 1(pcDNA 3.1/NS1),后者作为可能参与保护性免疫的 B 细胞和 T 细胞表位的来源。我们发现,用 pcDNA 3.1/E 和/或 pcDNA 3.1/NS1 这两种质粒的三个初免剂量免疫 BALB/c 小鼠,能够用单个质粒诱导针对 E 蛋白的抗体反应;与针对 NS1 蛋白的抗体反应不同,我们在抗体反应方面观察到了累加效应。此外,采用一种初免-加强方案,即同时给予两种质粒构建体,随后用同源的 GST-E 和 GST-NS1 重组蛋白进行加强免疫,我们观察到与单独用这些蛋白或登革构建体免疫的动物相比,针对 NS1 和 E 蛋白的抗体反应有所增强。如果中和抗体在登革热感染中起重要作用,那么用该方案产生的抗体也明显优于单独给予蛋白混合物。这些结果表明,在亚单位重组疫苗的设计中可以考虑将 NS1 和 E 蛋白结合起来。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验